News GenoScreen Expertise

GenoScreen will be present at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) on April 13 in Amsterdam.

Deeplex®-MycTB, was used in a study published in The Lancet Infectious Diseases highlighting the spread of tuberculosis strains resistant to first-line antibiotics, not detected by current diagnostic tests.

GenoScreen will participate in the 1st edition of the POLEPHARMA Microbiomics Days which will be organized on April 9 & 10 at the HEALTH UFR of the University of Rouen.

Discover Deeplex-MycTB, a next-generation molecular analysis solution that allows, in a single test,

  • to identify the mycobacteria of the M. tuberculosis complex causing tuberculosis,
  • to predict their resistance to multiple antibiotics of first and second intent
  • and to type them for epidemiological surveillance purposes.

Metabiote®, the reference protocol in targeted metagenomics developed by GenoScreen, is now GCLP compliant.